Programming probiotics for early detection of liver cancer metastases

Scientists have discovered a new method for detecting liver cancer metastases - over-the-counter probiotics. Researchers at University of California, San Diego and the Massachusetts Institute of Technology (MIT) use genetically programmed probiotics in mice to produce signals easily detectable in urine when liver cancer metastases are present.

To continue reading this article, please Log In or Sign Up for access.